The 1st International Symposium on Molecular-targeted Therapy

Congress President Yoshiya Tanaka

Professor and Chairman, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushi, Japan

The International Symposium on Molecular Targeted Therapy was established to bring together scientists, researchers, and clinicians from Japan and abroad to form a new community and to discuss new science and therapies. The symposium aims to disseminate cutting-edge scientific knowledge, pioneering research, and ground-breaking clinical practice. It will include keynote addresses focusing on the latest advances and challenges in molecular targeted therapies, comprehensive workshops, and panel discussions, with an emphasis on systemic autoimmune rheumatic diseases, that will provide in-depth insights. Beyond the above disease areas, there will also be in-depth exploration of new areas of genetic engineering, the complexity of signaling pathways, and groundbreaking advances in immunotherapy using biologics, small molecule inhibitors and cell-based molecular therapies.